Core Scientific’s stock performance triggers mandatory conversion of $260 million in secured convertible notes due in 2029.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Leave a Reply